Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients.

about

CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator.Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

P2860

Q41174483-9AB9F19F-F402-4FA0-8763-11CB7F2C37EA Q52717613-64D23872-7167-437A-A6C6-5B35C26131B5

P2860

Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients.

Item

http://www.wikidata.org/entity/Q53564503

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Correlation of genetic polymor ...... lung adenocarcinoma patients.

@en

Correlation of genetic polymor ...... lung adenocarcinoma patients.

@nl

type

Item

label

Correlation of genetic polymor ...... lung adenocarcinoma patients.

@en

Correlation of genetic polymor ...... lung adenocarcinoma patients.

@nl

prefLabel

Correlation of genetic polymor ...... lung adenocarcinoma patients.

@en

Correlation of genetic polymor ...... lung adenocarcinoma patients.

@nl

P1476

Correlation of genetic polymor ...... lung adenocarcinoma patients.

@en

P2093

Hye In Woo

http://www.w3.org/2001/XMLSchema#string

Hyun Ae Jung

http://www.w3.org/2001/XMLSchema#string

Ji Yean Lee

http://www.w3.org/2001/XMLSchema#string

Jin Seok Ahn

http://www.w3.org/2001/XMLSchema#string

Jong-Mu Sun

http://www.w3.org/2001/XMLSchema#string

Jung A Kim

http://www.w3.org/2001/XMLSchema#string

Ka-Kyung Kim

http://www.w3.org/2001/XMLSchema#string

Keunchil Park

http://www.w3.org/2001/XMLSchema#string

Myung-Ju Ahn

http://www.w3.org/2001/XMLSchema#string

Soo-Youn Lee

http://www.w3.org/2001/XMLSchema#string

P2860

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer.

Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.

Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.

Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas.

Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.

The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.

Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.

P304

383-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.15.14

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25823786

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients.

about

P2860

P2860

Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921